Drug
Rfixfc
Rfixfc: highest development phase Phase 3, developed by Sanofi, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| rFIXFc NCT02234310 | Phase 3 | Hemophilia B |
| rFIXFc NCT01440946 | Phase 3 | Hemophilia B |
Latest
No recent events.
Follow Rfixfc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.